Diagnosing rheumatic disease can be challenging because of protean manifestations and unexplained clinical features. We present two cases of multiple myeloma masquerading as rheumatic diseases, and describe how potential misdiagnoses were avoided. The first patient presented with thickened skin, mimicking systemic sclerosis. This was actually multiple myeloma manifesting an extremely rare cutaneous paraneoplastic phenomena; "Scleromyxedema". The second patient presented with acute monocular blindness and high erythrocyte sedimentation rate (ESR), initially misdiagnosed as giant cell arteritis. However, this was also multiple myeloma with hyperviscosity causing blindness. It is important to consider differentials despite fulfilment of conventional criteria or clinical patterns in diagnosing rheumatic disease.
INtRODUctION
Multiple myeloma is a malignant neoplasm of plasma cells, characterised by excessive monoclonal immunoglobulin production. The disorder often manifests in ways related to the destructive infiltration of plasma cells into bone and the pathological effect of immunoglobulins (Ig) on vital organs. A review of 1027 newly diagnosed patients by the Mayo Clinic 1 , revealed predominant clinical presentations to be anaemia (73%), bone pain (58%), elevated creatinine (48%), fatigue (32%), hypercalcaemia (28%), and weight loss (24%). The International Myeloma Working Group 2 coined the acronym "CRAB", for hypercalcaemia, renal insufficiency, anaemia and bone lesions.
However, up to 20% of patients can present without a "CRAB" feature, and instead have neuropathy, hyperviscosity syndrome, concomitant amyloidosis, and haemorrhage or coagulopathy (in decreasing order of frequency) 3 . For patients within this non-"CRAB" category, important diagnostic challenges exist with potentially devastating consequences if vital investigations and management plans are misaligned. We present two patients with multiple myeloma presenting atypically as mimics of rheumatological conditions. We discuss how misdiagnoses were avoided, and include a short review of the literature.
CASE 1 -The Man with Thick Skin
A 79-year-old gentleman, with background comorbidities of hypertension, chronic obstructive pulmonary disease and benign prostate hyperplasia, was investigated for general ill-health with normochromic normocytic anaemia. His haemoglobin concentration was 9.7g/dL, while iron, folate and vitamin B12 levels were normal. Antral gastritis was found on gastroscopy while colonoscopy was unremarkable. Computed tomography (CT) of his thorax showed a left mid-zone bullae but no evidence of interstitial fibrosis. Pulmonary function tests revealed a mild irreversible obstructive pattern. A small pericardial effusion was also detected on an echocardiogram.
The most important clinical findings were on the skin. The patient had an eczematous rash with lichenification and hyperpigmentation on his thighs. He had been on follow-up with a dermatologist for chronic eczema and was prescribed topical steroids. A more careful Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 examination revealed extensive thickening of the skin predominantly in the trunk, affecting large areas of the back and chest, but also affecting the extensor surfaces of the thighs and arms ( Fig. 1 ).
In view of the diffuse thickening of the skin, a diagnosis of systemic sclerosis was provisionally made by the General Medical team. The patient seemed to have the major criterion of proximal scleroderma following the preliminary criteria for the classification of systemic sclerosis by the American College of Rheumatology (ACR) 4 . Perplexingly, the patient did not have any symptoms of Raynaud's phenomenon and there was no sclerodactyly and no digital pitting scars (Fig. 2 ). The absence of Raynaud's phenomenon and the sparing of the fingers were highly unusual for systemic sclerosis. A "pseudo-scleroderma" state, specifically, scleromyxedema rather than systemic sclerosis was diagnosed by the rheumatologist.
Investigations revealed a raised ESR of >140mm/1st hour, and C-reaction protein (CRP) 29.4mg/L. Tests for antinuclear antibody (ANA) and extractable nuclear antigen (ENA) antibodies were negative. As scleromyxedema is known to be associated with paraproteinaemia, a myeloma panel was ordered. This confirmed the diagnosis of multiple myeloma. The Ig levels were deranged, with IgA 22.1g/L (0. and IgE 176 IU/mL (0-87). A monoclonal band was detected and immunotyped as IgA Lambda. The bone marrow cellularity was 30%, with an infiltrate of CD138 plasma cells. Multiple myeloma fluorescence in situ hybridisation, showed the presence of an abnormal clone with trisomy 4 and RB1 gene deletion. The corrected serum calcium level was normal.
This was not systemic sclerosis. This was multiple myeloma presenting atypically with a scleroderma-like thickening of the skin. Mimicking systemic sclerosis was an extremely rare cutaneous paraneoplastic phenomena, termed scleromyxedema.
CASE 2 -The Lady with Acute Monocular Blindness and High ESR
A 60-year-old Malay lady, with a background history of poorly controlled diabetes (3.5 years), hypertension (2.5 years) and hyperlipidaemia, presented with a sudden loss of vision in her left eye four days prior to admission. This loss of vision was painless and persistent. She did not have symptoms of headache, jaw claudication or unexplained fever. Symptoms of polymyalgia rheumatica, like aching pains in the limb girdles, were absent. She also did not have any complaints of episodic neurological deficits to suggest multiple sclerosis.
At admission, her blood pressure was 170/80mmHg. Vision of the left eye was significantly impaired, with the best measurable acuity being the ability to perceive hand movements. Fundoscopy revealed a pale swollen disc on the left side with peripapillary haemorrhages. There was also silver wiring with some hard and soft exudates in both eyes as well as scars from previous laser therapy. The fundal fluorescein angiogram confirmed a congested disc with tortuosity and engorgement particularly affecting the superior temporal retinal vein of the left eye. The retinal images and fundal fluorescein angiography are shown in Fig. 3 . The impression There are many causes of AION. Both arteritic and non-arteritic pathologies could give rise to similar ocular findings. Diabetes and hypertension put her at risk for non-arteritic AION. However with a high ESR of >140mm/1st hour, the diagnosis of giant cell arteritis (GCA) was deemed likely. Empiric treatment with prednisolone 60mg daily was immediately started while a temporal artery biopsy of adequate length (>20mm) was ordered. However, histological examination of the temporal artery showed no evidence of any inflammatory or granulomatous infiltrate within the walls of the temporal artery. Magnetic resonance imaging of the brain did not display any plaques (which would suggest multiple sclerosis with optic neuritis) or any compressive/infiltrative neoplasia (like optic glioma, metastatic disease). Magnetic resonance angiography was also performed and showed no gross vascular pathologies.
The cause of her optic neuropathy was uncertain at this point. The negative temporal artery biopsy, the absence of headache, jaw claudication, fever and symptoms of polymyalgia rheumatica with a normal CRP despite the very high ESR suggested that this might not be GCA. A myeloma panel was ordered and returned abnormal. The Ig levels were deranged with IgA 53.0g/L (0.8-4). A monoclonal band was detected and immunotyped as IgA Kappa. The raised ESR was not due to GCA but was due to multiple myeloma. A review of the retinal images was performed in retrospect, and this supported the diagnosis of hyperviscosity syndrome. Multiple myeloma presented atypically in this instance, with a hyperviscosity syndrome causing blindness. We immediately transferred care to the haematologist for plasmapheresis. Her vision promptly improved with therapy.
DIscUssION
Not all patients with thickened skin have systemic sclerosis. Drugs, toxins, or harmful environmental factors, endocrine diseases (like diabetes mellitus) and infiltrative disorders can also cause scleroderma-like skin. Scleromyxedema (or papular mucinosis/lichen myxedematosus) is an extremely rare skin disorder characterised by mucinous infiltration, sclerosis of the skin and a monoclonal gammopathy. Localised or generalised areas of skin are afflicted with firm, flesh coloured papules and plaques which are waxy and mucinous in nature 5 . These lesions can appear erythematous (due to inflammation) and may coalesce to form large generalised surface areas of thickened skin. In prolonged disease, sclerodactyly, Raynaud's phenomenon, oesophageal dysmotility, myopathy, pulmonary hypertension, and other systemic manifestations can also develop 6 . In this regard, scleromyxedema can therefore resemble or mimic systemic sclerosis.
The exact prevalence of scleromyxedema is unknown; only about 150 cases have been described in the literature to date. However, it is nevertheless a distinct clinical entity, with three important features setting it cogently apart from systemic sclerosis. Firstly, in distribution, the middle portion of the back is commonly affected in scleromyxedema, but almost never involved in systemic sclerosis 7 . Secondly, in textural terms, the development of papules, especially in linear arrays, is also significantly distinguishing 8 . Systemic sclerosis is comparatively smoother, nonpapular and tight in nature, distinctly different from scleromyxedematous skin which is folded, irregular and pendulous in nature. Thirdly, the histological characteristics of scleromyxedema on biopsy show fibroblasts, collagen, chronic inflammatory cell infiltrate and in particular, acid mucopolysaccharides deposited in the papillary and reticular dermis. This unique mucinous substance can be identified using colloidal iron, toluidine blue or Alcian blue stains 9 . Unfortunately, we were unable to obtain a skin biopsy from this patient. Nevertheless, the suspicion of the diagnosis of scleromyxedema was so strong that we searched for and found a paraprotein and made the diagnosis of multiple myeloma.
A very important clue that this patient did not have systemic sclerosis was the absence of Raynaud's phenomenon. Raynaud's phenomenon is present in almost all patients with systemic sclerosis. The ACR criteria and the very early diagnosis of systemic sclerosis (VEDOSS) 10 consider Raynaud's phenomenon a major criterion essential for the diagnosis of early systemic sclerosis as well as for the diagnosis of very early systemic sclerosis 11 . The distribution of skin thickening was another clue. Almost all patients with systemic sclerosis have sclerodactyly and skin involvement of the hands and face. The fingers, hands and face of this patient Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 were spared. The very high ESR of >140 mm/1st hour is also unusual in systemic sclerosis. Patients who are known to have systemic sclerosis but have such a high ESR often have myositis or an overlap syndrome or may have a superimposed infection or another condition.
The second patient was initially suspected to have GCA based on the fundoscopic features of AION and a high ESR. AION due to ischaemia of the optic nerve is the most common ocular presentation of GCA and patients with GCA can also develop monocular blindness due to ischaemia of the retina and choroid 12 . Hence it was important to treat for GCA even before the temporal artery biopsy. Treatment must not be withheld while awaiting the temporal artery biopsy when the suspicion of GCA is high and the patient has complications like visual loss 13 . In instances when the suspicion remains high but the temporal artery biopsy is negative, treatment with steroids should be continued. However, our patient did not have any other clinical features of GCA. Furthermore her CRP was normal despite the high ESR. The diagnosis of multiple myeloma was suspected and confirmed. Another ophthalmologist reviewed the fundal photos and diagnosed hyperviscosity syndrome. The ESR is often low in hyperviscosity syndrome but can also be elevated. This has been described in rheumatoid arthritis patients with hyperviscosity syndrome 14 .
Multiple myeloma is one of the leading causes of hyperviscosity syndrome 15 , second only to Waldenstrom's macroglobulinemia. The estimated prevalence of hyperviscosity syndrome is 2-6% 16 in myeloma patients. As reflected in our case, IgA is often the predominant globulin involved, responsible in about 25% of cases 17 . Hypergammaglobulinemia increases serum viscosity, and therefore mechanically predisposes to haematological stasis and coagulation. This risks complications in many end organs particularly the eye, due to its minute vascularity and sensitivity to hypoxia.
Specific to the eye, sequelae of hyperviscosity include microaneurysms in the retinal periphery, retinal hypoxia secondary to vascular stasis or thrombosis 18, 19 , neovascularisation with vitreous haemorrhage, retinal detachment 20 , central retinal vein occlusion, micro-haemorrhage, exudates formation, and papilloedema. However, varied aetiologies (like diabetes) can also present with these non-specific retinal features. Our patient also had retinal vein engorgement affecting the left superior temporal, a typical feature seen in multiple myeloma 21 .
This case report illustrates the importance of considering differential diagnoses despite fulfilment of conventional criteria or clinical patterns for diagnosis. A high index of suspicion and an open mind is always extremely useful, especially in circumstances where presentations are atypical and the evidence confounding. We have illustrated how multiple myeloma can mimic rheumatic conditions in these two instances. It is our hope that such seeds sown will stimulate a harvest of clinicians, not only with exceptional capabilities in critical thinking and acumen, but also with discernible abilities to avoid the potential pitfalls of dogma or algorithmic practice, to ultimately serve our patients' best interest.
